{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:49:36Z","timestamp":1782496176145,"version":"3.54.5"},"posted":{"date-parts":[[2026,6,24]]},"group-title":"Microbiology","reference-count":83,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,24]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  Tuberculosis (TB) remains a leading global cause of infectious mortality due, in part, to the limited efficacy of the\n                  <jats:italic>Mycobacterium bovis<\/jats:italic>\n                  BCG vaccine against pulmonary TB. Previous studies in mice have shown that stimulating type I interferon (IFN) signaling during BCG vaccination can bolster protection against\n                  <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                  , yet clinically feasible delivery strategies for this approach are lacking. Adenoviral vectors, which induce potent type I IFN responses and are utilized in approved vaccine platforms, represent a promising adjuvant strategy. To evaluate the host immune response to this combination, bone marrow-derived murine macrophages were co-infected with replication-deficient adenovirus and BCG. Adenovirus-infected macrophages elicited a robust type I IFN response via the cGAS\/STING pathway. Compared to BCG infection alone, co-infected macrophages exhibited additive expression of genes with known host-protective roles against\n                  <jats:italic>M. tuberculosis<\/jats:italic>\n                  . Conversely, co-infection with BCG suppressed adenovirus-induced type I IFN signaling and diminished the production of IFN-stimulated genes compared to adenovirus infection alone. Together, these findings reveal a complex regulatory interplay during adenovirus and BCG co-infection. While BCG partially restricts adenoviral IFN induction, the co-infection still drives an enhanced host-protective gene profile, suggesting that adenoviral vectors could serve as a viable platform to modulate innate immunity and improve BCG vaccine efficacy.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>IMPORTANCE<\/jats:title>\n                  <jats:p>\n                    Tuberculosis (TB) remains the leading cause of death by a single infectious organism with approximately 1.25 million deaths annually.\n                    <jats:italic>M. bovis<\/jats:italic>\n                    BCG remains the only approved vaccine for TB; however, its efficacy against the contagious and most common pulmonary form of the disease is limited. There have been numerous attempts to improve BCG efficacy, but these approaches have not resulted in any clinically approved vaccine. We propose that BCG combined with a replication-deficient adenovirus presents a way to bolster vaccine-conferred protection as the combination may elicit a robust innate immune response and drive a more protective T cell response. Moreover, BCG and replication-deficient adenoviruses have well-assessed safety profiles and decades of studies regarding their use in patients. The significance of our work is in leveraging their complementary immunology to function as a combined vaccine platform. This approach presents a novel and clinically feasible approach to improve the BCG vaccine.\n                  <\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.06.24.734229","type":"posted-content","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:43:43Z","timestamp":1782369823000},"source":"Crossref","is-referenced-by-count":0,"title":["Replication-deficient Adenovirus 5 Serotypes Induce Type I Interferon and enhance BCG-mediated Immune Response in Co-infected Murine Macrophages"],"prefix":"10.64898","author":[{"given":"Joseph A.","family":"Vecchio","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA"},{"name":"The Berthiaume Institute for Precision Health, University of Notre Dame, Notre Dame, IN 46556, USA"},{"name":"Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Schorey","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA"},{"name":"The Berthiaume Institute for Precision Health, University of Notre Dame, Notre Dame, IN 46556, USA"},{"name":"Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026062610051059000_2026.06.24.734229v1.1","unstructured":"2025. Global tuberculosis report 2025."},{"key":"2026062610051059000_2026.06.24.734229v1.2","doi-asserted-by":"crossref","first-page":"e1307","DOI":"10.1016\/S2214-109X(22)00283-2","article-title":"Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis","volume":"10","year":"2022","journal-title":"The Lancet Global Health"},{"key":"2026062610051059000_2026.06.24.734229v1.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4643"},{"key":"2026062610051059000_2026.06.24.734229v1.4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","year":"2006","journal-title":"The Lancet"},{"key":"2026062610051059000_2026.06.24.734229v1.5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit790"},{"key":"2026062610051059000_2026.06.24.734229v1.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4643"},{"key":"2026062610051059000_2026.06.24.734229v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/nri3787"},{"key":"2026062610051059000_2026.06.24.734229v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/nri3581"},{"key":"2026062610051059000_2026.06.24.734229v1.9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1080\/1040841X.2023.2294904","article-title":"Activation of host nucleic acid sensors by Mycobacterium : good for us or good for them?","volume":"50","year":"2024","journal-title":"Critical Reviews in Microbiology"},{"key":"2026062610051059000_2026.06.24.734229v1.10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180325"},{"key":"2026062610051059000_2026.06.24.734229v1.11","first-page":"e01481","article-title":"The dual role of type I interferons in bacterial infections: from immune defense to pathogenesis","volume":"16","year":"2025","journal-title":"mBio"},{"key":"2026062610051059000_2026.06.24.734229v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2025.11.003"},{"key":"2026062610051059000_2026.06.24.734229v1.13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180508"},{"key":"2026062610051059000_2026.06.24.734229v1.14","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2017.1321191"},{"key":"2026062610051059000_2026.06.24.734229v1.15","doi-asserted-by":"publisher","DOI":"10.1086\/345862"},{"key":"2026062610051059000_2026.06.24.734229v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3813"},{"key":"2026062610051059000_2026.06.24.734229v1.17","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.4049\/jimmunol.178.5.3143","article-title":"The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis","volume":"178","year":"2007","journal-title":"The Journal of Immunology"},{"key":"2026062610051059000_2026.06.24.734229v1.18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1911646117"},{"key":"2026062610051059000_2026.06.24.734229v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2012.03.007"},{"key":"2026062610051059000_2026.06.24.734229v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19412-6"},{"key":"2026062610051059000_2026.06.24.734229v1.21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20250466"},{"key":"2026062610051059000_2026.06.24.734229v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.11.002"},{"key":"2026062610051059000_2026.06.24.734229v1.23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006687"},{"key":"2026062610051059000_2026.06.24.734229v1.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045839"},{"key":"2026062610051059000_2026.06.24.734229v1.25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026938"},{"key":"2026062610051059000_2026.06.24.734229v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/nature09247"},{"key":"2026062610051059000_2026.06.24.734229v1.27","first-page":"1","article-title":"IFN- \u03b1 Boosting of Mycobacterium bovis Bacillus Calmette G\u00fcerin-Vaccine Promoted Th1 Type Cellular Response and Protection against M. tuberculosis Infection","volume":"2017","year":"2017","journal-title":"BioMed Research International"},{"key":"2026062610051059000_2026.06.24.734229v1.28","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0908583"},{"key":"2026062610051059000_2026.06.24.734229v1.29","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.celrep.2017.02.057","article-title":"Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection","volume":"18","year":"2017","journal-title":"Cell Reports"},{"key":"2026062610051059000_2026.06.24.734229v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.083"},{"key":"2026062610051059000_2026.06.24.734229v1.31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013992"},{"key":"2026062610051059000_2026.06.24.734229v1.32","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz116"},{"key":"2026062610051059000_2026.06.24.734229v1.33","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3389\/fimmu.2019.01519","article-title":"Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous Adjuvant Induces Elevated Immune Responses After Mycobacterium tuberculosis Infection","volume":"10","year":"2019","journal-title":"Front Immunol"},{"key":"2026062610051059000_2026.06.24.734229v1.34","doi-asserted-by":"crossref","first-page":"139.4","DOI":"10.4049\/jimmunol.202.Supp.139.4","article-title":"SOCS1 antagonist-expressing recombinant BCG enhances anti-tuberculosis protection in a mouse model","volume":"202","year":"2019","journal-title":"The Journal of Immunology"},{"key":"2026062610051059000_2026.06.24.734229v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2021.100432"},{"key":"2026062610051059000_2026.06.24.734229v1.36","doi-asserted-by":"publisher","DOI":"10.3390\/v16071094"},{"key":"2026062610051059000_2026.06.24.734229v1.37","doi-asserted-by":"crossref","first-page":"2667742","DOI":"10.1080\/14760584.2026.2667742","article-title":"Novel vaccine platforms for respiratory viruses: a review of licensed vaccines and candidates in late-stage development","volume":"25","year":"2026","journal-title":"Expert Review of Vaccines"},{"key":"2026062610051059000_2026.06.24.734229v1.38","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02608-14"},{"key":"2026062610051059000_2026.06.24.734229v1.39","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01926-06"},{"key":"2026062610051059000_2026.06.24.734229v1.40","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02702-13"},{"key":"2026062610051059000_2026.06.24.734229v1.41","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00517-06"},{"key":"2026062610051059000_2026.06.24.734229v1.42","doi-asserted-by":"crossref","first-page":"1492268","DOI":"10.3389\/fmicb.2025.1492268","article-title":"Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis","volume":"16","year":"2025","journal-title":"Front Microbiol"},{"key":"2026062610051059000_2026.06.24.734229v1.43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005856"},{"key":"2026062610051059000_2026.06.24.734229v1.44","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/j.vaccine.2016.06.032","article-title":"Parenteral adenoviral boost enhances BCG induced protection, but not long term survival in a murine model of bovine TB","volume":"34","year":"2016","journal-title":"Vaccine"},{"key":"2026062610051059000_2026.06.24.734229v1.45","doi-asserted-by":"crossref","first-page":"e81317","DOI":"10.1371\/journal.pone.0081317","article-title":"A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression","volume":"8","year":"2013","journal-title":"PLoS ONE"},{"key":"2026062610051059000_2026.06.24.734229v1.46","doi-asserted-by":"crossref","first-page":"18703","DOI":"10.1038\/s41598-020-75734-x","article-title":"Airway delivery of both a BCG prime and adenoviral boost drives CD4 and CD8 T cells into the lung tissue parenchyma","volume":"10","year":"2020","journal-title":"Sci Rep"},{"key":"2026062610051059000_2026.06.24.734229v1.47","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5304.1320"},{"key":"2026062610051059000_2026.06.24.734229v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/nm952"},{"key":"2026062610051059000_2026.06.24.734229v1.49","first-page":"e00670","article-title":"Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages","volume":"8","year":"2017","journal-title":"mBio"},{"key":"2026062610051059000_2026.06.24.734229v1.50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/15384047.2017.1395115","article-title":"A novel fiber chimeric conditionally replicative adenovirus-Ad5\/F35 for tumor therapy","volume":"18","year":"2017","journal-title":"Cancer Biology & Therapy"},{"key":"2026062610051059000_2026.06.24.734229v1.51","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02192-06"},{"key":"2026062610051059000_2026.06.24.734229v1.52","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02685-06"},{"key":"2026062610051059000_2026.06.24.734229v1.53","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1432-1033.2004.04011.x","article-title":"NF-\u03baB- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer\/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7","volume":"271","year":"2004","journal-title":"European Journal of Biochemistry"},{"key":"2026062610051059000_2026.06.24.734229v1.54","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/biot.201400744","article-title":"NF-\u03baB, CRE and YY1 elements are key functional regulators of CMV promoter-driven transient gene expression in CHO cells","volume":"10","year":"2015","journal-title":"Biotechnology Journal"},{"key":"2026062610051059000_2026.06.24.734229v1.55","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12306"},{"key":"2026062610051059000_2026.06.24.734229v1.56","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.1801303","article-title":"Mycobacterium tuberculosis Inhibits Autocrine Type I IFN Signaling to Increase Intracellular Survival","volume":"202","year":"2019","journal-title":"The Journal of Immunology"},{"key":"2026062610051059000_2026.06.24.734229v1.57","first-page":"e00376","article-title":"Primary Role of Suppressor of Cytokine Signaling 1 in Mycobacterium bovis BCG Infection","volume":"86","year":"2018","journal-title":"Infect Immun"},{"key":"2026062610051059000_2026.06.24.734229v1.58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0928-8244(03)00231-1","article-title":"Mycobacterium bovis bacillus Calmette-Guerin infection promotes SOCS induction and inhibits IFN-\u00ce3-stimulated JAK\/STAT signaling in J774 macrophages","volume":"39","year":"2003","journal-title":"FEMS Immunology & Medical Microbiology"},{"key":"2026062610051059000_2026.06.24.734229v1.59","doi-asserted-by":"crossref","first-page":"1739628","DOI":"10.3389\/fimmu.2026.1739628","article-title":"Pharmacological inhibition of USP18 improves antibacterial responses and the intracellular control of Mycobacterium tuberculosis in macrophages","volume":"17","year":"2026","journal-title":"Front Immunol"},{"key":"2026062610051059000_2026.06.24.734229v1.60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1054\/tuld.2000.0247","article-title":"Monocyte-derived macrophage cytokine responses induced by M. bovis BCG","volume":"80","year":"2000","journal-title":"Tubercle and Lung Disease"},{"key":"2026062610051059000_2026.06.24.734229v1.61","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4049\/jimmunol.158.1.330","article-title":"IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses","volume":"158","year":"1997","journal-title":"J Immunol"},{"key":"2026062610051059000_2026.06.24.734229v1.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2005.03.010"},{"key":"2026062610051059000_2026.06.24.734229v1.63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41419-020-03332-w","article-title":"Apoptosis inhibitor of macrophage (AIM) contributes to IL-10-induced anti-inflammatory response through inhibition of inflammasome activation","volume":"12","year":"2021","journal-title":"Cell Death Dis"},{"key":"2026062610051059000_2026.06.24.734229v1.64","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.4049\/jimmunol.170.3.1174","article-title":"IFN-\u03b1\u03b2 Released by Mycobacterium tuberculosis -Infected Human Dendritic Cells Induces the Expression of CXCL10: Selective Recruitment of NK and Activated T Cells","volume":"170","year":"2003","journal-title":"The Journal of Immunology"},{"key":"2026062610051059000_2026.06.24.734229v1.65","doi-asserted-by":"crossref","first-page":"828439","DOI":"10.3389\/fcimb.2022.828439","article-title":"Increased Interferon-Induced Protein With Tetracopeptides (IFITs) Reduces Mycobacterial Growth","volume":"12","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2026062610051059000_2026.06.24.734229v1.66","doi-asserted-by":"crossref","first-page":"1536446","DOI":"10.3389\/fcimb.2025.1536446","article-title":"IFIT2-induced transcriptomic changes in Mycobacterium tuberculosis infected macrophages","volume":"15","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"2026062610051059000_2026.06.24.734229v1.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2008.07.008"},{"key":"2026062610051059000_2026.06.24.734229v1.68","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit424"},{"key":"2026062610051059000_2026.06.24.734229v1.69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30914-3"},{"key":"2026062610051059000_2026.06.24.734229v1.70","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.it.2024.07.008","article-title":"Unmasking the hidden impact of viruses on tuberculosis risk","volume":"45","year":"2024","journal-title":"Trends in Immunology"},{"key":"2026062610051059000_2026.06.24.734229v1.71","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1109742"},{"key":"2026062610051059000_2026.06.24.734229v1.72","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.4049\/jimmunol.1600584","article-title":"Type I IFN Inhibits Alternative Macrophage Activation during Mycobacterium tuberculosis Infection and Leads to Enhanced Protection in the Absence of IFN-\u03b3 Signaling","volume":"197","year":"2016","journal-title":"The Journal of Immunology"},{"key":"2026062610051059000_2026.06.24.734229v1.73","doi-asserted-by":"crossref","first-page":"e2425309122","DOI":"10.1073\/pnas.2425309122","article-title":"ACOD1-mediated lysosomal membrane permeabilization contributes to Mycobacterium tuberculosis \u2013induced macrophage death","volume":"122","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026062610051059000_2026.06.24.734229v1.74","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.4049\/jimmunol.1700515","article-title":"Nitric Oxide Modulates Macrophage Responses to Mycobacterium tuberculosis Infection through Activation of HIF-1\u03b1 and Repression of NF-\u03baB","volume":"199","year":"2017","journal-title":"The Journal of Immunology"},{"key":"2026062610051059000_2026.06.24.734229v1.75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.10.5243"},{"key":"2026062610051059000_2026.06.24.734229v1.76","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180118"},{"key":"2026062610051059000_2026.06.24.734229v1.77","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.4049\/jimmunol.175.5.3318","article-title":"Expression of Many Immunologically Important Genes in Mycobacterium tuberculosis -Infected Macrophages Is Independent of Both TLR2 and TLR4 but Dependent on IFN-\u03b1\u03b2 Receptor and STAT1","volume":"175","year":"2005","journal-title":"The Journal of Immunology"},{"key":"2026062610051059000_2026.06.24.734229v1.78","doi-asserted-by":"crossref","unstructured":"Wu R , Chen F , Wang N , Tang D , Kang R. 2020. ACOD1 in immunometabolism and disease.","DOI":"10.1038\/s41423-020-0489-5"},{"key":"2026062610051059000_2026.06.24.734229v1.79","unstructured":"Cell Mol Immunol 17:822\u2013833."},{"key":"2026062610051059000_2026.06.24.734229v1.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2007.02.016"},{"key":"2026062610051059000_2026.06.24.734229v1.81","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.1302779","article-title":"The Fli-1 Transcription Factor Regulates the Expression of CCL5\/RANTES","volume":"193","year":"2014","journal-title":"The Journal of Immunology"},{"key":"2026062610051059000_2026.06.24.734229v1.82","doi-asserted-by":"publisher","DOI":"10.1038\/srep43578"},{"key":"2026062610051059000_2026.06.24.734229v1.83","doi-asserted-by":"crossref","first-page":"e0281564","DOI":"10.1371\/journal.pone.0281564","article-title":"Mycobacterium tuberculosis SecA2-dependent activation of host Rig-I\/MAVs signaling is not conserved in Mycobacterium marinum","volume":"19","year":"2024","journal-title":"PLoS ONE"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.24.734229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:05:26Z","timestamp":1782493526000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.06.24.734229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":83,"URL":"https:\/\/doi.org\/10.64898\/2026.06.24.734229","relation":{},"subject":[],"published":{"date-parts":[[2026,6,24]]},"subtype":"preprint"}}